Innovation Pharmaceuticals Inc (IPIX)

[DesireToLearn]

It's my understanding P2a was not designed for stats significance. I also understand it was designed with high bar hurdles. Even with this, 200mg showed signs of efficacy and on par with Otezla in some ways. So, low dosage and yet still achieved that combined with strong positive clinical testing. More signs point to good enough sucess vs failure in my opinion. I understand the points you have made in the past, but I think signs point to more optimizism than less.